BioTelemetry, Inc. Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
BioTelemetry (BEAT) Tops Q1 EPS by 1c; Raises Revenue Otulook
April 25, 2019 4:08 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $104 million versus the consensus estimate of $104.11 million.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented: The first quarter was another great quarter with record revenue and a strong adjusted EBITDA margin, both of which were in line with our expectations.... More
